Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Pharmaceutical Sciences Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Euro Antibiotics 2021

About conference

We welcome all the participants from everywhere the world to attend Euro Antibiotics 2021 to be persisted on October 21-22, 2021, which incorporates prompt keynote presentations, Oral talks, Poster presentations.
 
Conference Series LLC Ltd is organizing 2nd Annual Congress on Antibiotics and Bacterial Infections on October 21-22, 2021. We organize Antimicrobial Meetings within the fields associated with Antibacterial Studies and Research.
 
The use of antibiotics having a crucial concern for selection of resistance, not completely among pathogenic bacteria also among the commensal ones. publicly health antimicrobial resistance may be a major problem thanks to possibility in therapeutic failure. the first objective of this meeting is to compile researchers involved in antibiotic and Bacterial Infections  prevention and control. The meeting will take a unified approach to research and it'll cause researchers specializing in several subjects associated with antibiotics and Bacterial Infections. We expected to present a universal vision of the importance of antimicrobial and Bacterial Infections in several ecosystems and what are often done about it.

Why to attend

EURO ANTIBIOTICS 2021 may be a platform to debate and study the newest advancements within the field of Antibiotics because the world's consideration turned regarding the urgency of latest antibiotics because the antimicrobial resistance and Bacterial Infections is growing day by day. Many developed nations and International health organizations try to focus of the present situation and making new policies to stop the adverse effects of Bacterial Infections.
 
The 2-day webinar gathers researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working within the field of Antibiotics to understand the newest developments and therefore the current situation of the Antibiotic & Bacterial Infections
Who will attend and Who you'll meet
2nd Annual Congress on Antibiotics and Bacterial Infections is exclusively designed for:
 
Researchers
Academia
Drug Manufacturers
Government agencies
Healthcare professionals
Hospitals/ Clinics
Methodologists
Young investigators
Medical Directors
Principal Investigators
Clinical Research organizations
Senior executives of Biotech, Biomedical, Medical devices and Pharmaceutical industries.
 
This conference lays a platform for all the researchers working within the field of microbiology/antibiotics to understand the newest developments and therefore the current situation of the Antibiotics and Bacterial Infections problem. We welcome all the participants from everywhere the planet to attend 2nd Annual Congress on Antibiotics and Bacterial Infections to be persisted February 26-27, 2021 (Webinar) which incorporates prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Session & Tracks

Track 1: Antibiotics

Antibiotics are a kind of antimicrobials that are utilized in treatment and prevention of bacterial infections. they'll kill or inhibit the expansion of bacteria. Many antibiotics also are effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics aren't effective against viruses like cold or influenza, and should be harmful when taken inappropriately. Physicians must make sure the patient features a bacterial infection before prescribing antibiotics.

Related Associations

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunolog

Track 2: Antibiotics in several Industries

Antibiotics must be used accordingly in humans and animals because both uses share to the emergence, persistence, and escalation of resistant bacteria. Bacteria in food-producing animals are of particular concern. Food animals play as a source of resistant pathogens and resistance mechanisms which will directly or indirectly end in antimicrobial  infections in humans. Bacteria could also be transmitted to humans through the foods we eat. Some bacteria have turned immune to quite one kind of antibiotic, which makes it harder to treat the infections they cause. Sustaining the efficiency of antibiotic drugs is significant to insulating human and animal health.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology

Track 3: Clinical Trials of Antibiotics

Prescribing doctors are, progressively, using clinical trial data as a major source of information for evidence-based medicine for the remedy of infectious diseases, as in other clinical disciplines. However, it may be difficult to excerpt from these data the material that is needed for the management of the individual patient. At the same time, clinical trial testimony have been used, probably satisfactorily, in the process of drug registration, and the pharmaceutical industry has spent progressively large amount of money to satisfy the needs of this process. In the face of all these problems, switch in the way antibiotic clinical trials are designed and performed are clearly necessary, although this must not disturb the balance so far as to restore them less useful for those who currently derive greatest benefit from them.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology

Track 4: Subsequent Generation Approach of Antibiotics

The discovery of a replacement of antibiotic is called  teixobactin was announced by international team of researchers, in January this year. it's the foremost significant new antibiotic to be discovered in additional than 30 years, and it's going to help combat the growing number of drug-resistant bacteria.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology

Track 5: Alternative to Antibiotics

This  method uses the enzymes of bacteriophages to attack the bacteria. Bacteriophages are tiny viruses that infect bacteria. After they infect the bacteria, they replicate or make copies of themselves, then leave the bacteria to travel and infect other bacteria. To be ready to leave the bacteria, the "phages" make an enzyme that dissolves the wall of the bacterial cell, thus killing it.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology

Track 6: Origins and kinds of Antibiotic and Antimicrobials

The world is within the midst of an emerging crisis of antibiotic resistance to microbial pathogens. Numerous pathogens that became immune to commonly used antibiotics are described in various contexts, including drug-resistant methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumonia, and tubercle bacillus . Considering the breadth of effect and significant impact on morbidity and mortality, multi-drug-resistant (MDR) pathogens are a considerable threat to public health. Although this problem involves the event of latest antibiotics with new mechanisms of action, the pharmaceutical industry has abandoned the world as less lucrative for his or her investments. the amount of latest antibiotics approved by the U.S. Food and Drug Administration (FDA) declined dramatically during the past 2 decades.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology 

Track 7: Genetics and Proteomics of antimicrobial

Bacteria can acquire antimicrobial genes from other bacteria in several ways. By undergoing an easy mating process called "conjugation," bacteria can transfer genetic material, including genes encoding resistance to antibiotics (found on plasmids and transposons) from one bacterium to a different . Antibiotic resistance genes are identified in diverse environments including soil, gull feces and, increasingly, within the human gut microbiota. Scientists have applied a variety of approaches to detect antimicrobial genes in environmental or non-clinical microbiomes, all of which have their own inherent strengths/limitations.

Proteomic studies have improved our understanding of the microbial world. the foremost recent advances during this field have helped us to explore aspects beyond genomics. Proteomics has also advanced our knowledge of mechanisms of bacterial virulence and a few important aspects of how bacteria interact with human cells and, thus, of the pathogenesis of infectious diseases. we've used proteomic technology to elucidate the complex cellular responses of Bacillus subtilis to antimicrobial compounds belonging to classical and emerging antibiotic classes.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology

Track 8: Antimicrobial : Public Health Concerns

This topic reviews the worldwide antibiotic markets, including discussions on the market development and growth potential over subsequent 5 years. It also analyses key factors that are driving the market growth. It describes the trends intimately with reference to various antibiotic classes, including the novel classes that are emerging and their technological basis. It includes in-depth discussions of the industry structure and therefore the regulatory environment. it's valuable reading for investors, policymakers, and industry participants. Profiles of leading players within the industry also are included.

Such involved analyses are conducted to assist strategy developers and decision makers within pharmaceutical companies and government bodies. The detailed analyses of the regulatory factors that play major roles choose the industry trends are especially useful for legislators involved in government policy development programs. Technology trend and patent analyses give an summary of the new trends with reference to innovation within the world .

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology

Track 9: Antibiotic surveillance and safety concerns

In the time since penicillin was discovered nearly 80 years ago, antibiotics became one among the foremost important lifesaving weapons in doctors' arsenal against bacterial infection. Now, the Lakeland, Fla.-based Publix grocery chain is making a gift of seven of those drugs freed from charge to those that have prescriptions for them. Five of those are amoxicillin, ampicillin, cephalexin, erythromycin and penicillin VK -- are commonly employed by doctors to treat bacterial infections starting from ear infections to gonorrhea. But two of the drugs on the list -- ciprofloxacin and sulfamethoxazole/trimethoprim -- are high-grade antibiotics that doctors usually reserve for particularly serious infections.

While some hail the program as a godsend, others fear that the move could lead on to overuse of the drugs.

This is because the utilization of antibiotics comes attached with important considerations. consistent with the American Academy of Family Physicians, there are certain situations during which antibiotics are helpful -- and lots of during which they will cause more harm than good.

Penicillins, Cephalosporins, Aminoglycosides, Glycopeptides, Tetracyclines are antibiotics most ordinarily showing side effects.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology 

Track 10: Analytical strategies for Antimicrobials & Antibiotics

The analysis of antibiotic susceptibility disks by high-pressure liquid chromatography (HPLC) methods are presented for the potency determination of mecillinam, ampicillin, carbenicillin, and cephalotjiin alone and in various combinations. Good agreement between HPLC and microbiological data is observed for potency determinations with recoveries of greater than 95%. Relative standard deviations of less than 2% are recorded for every HPLC method. HPLC methods offer improved accuracy and greater precision in comparison to the quality microbiological methods of study for susceptibility disks. the foremost popular analytical methods for the determination of beta-lactams are the chromatographic ones, including high performance liquid-chromatography (HPLC) and thin layer chromatography (TLC).

HPLC offers high sensitivity and separation efficiency, establishing itself because the first choice method for the analysis of beta-lactams; however it's expensive and requires sophisticated equipment. TLC may be a less costly and fewer complicated chromatographic procedure, which may be successfully used, within the preliminary screening of pharmaceutical substances. In modern analysis, TLC is typically used as a separation method, which establishes the presence or absence of beta-lactam antibiotics above an outlined level of concentration.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology 

Track 11: Role of future antibiotics & antimicrobial in diseases

Antibiotics are applied for the treatment of autoimmune diseases for over five decades, supported the premise that infections play a task within the initiation and propagation of those entities. The antibiotics market was valued at USD 39.8 million in 2015 and is predicted to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the event of advanced products. consistent with the info published by the Pew public trust , in March 2016, about 37 promising molecules were being investigated within the U.S. market. Majority of those , are in phase II clinical trial clinical trials and are anticipated to hit the market between 2018 - 2020. Furthermore, supportive government legislations, like the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology 

Track 12: Infectious Diseases

This term is one among the weightage issues within the recent times. As discussed earlier, many new sorts of strains are coming into existence which creates infections even deadlier infections which is so called Infectious Diseases. Researchers of this sort , Infectious Diseases specialists are paid high and that they are considered to be a top niche says the study. does one agree and have you ever found any new strains, then submit your research article to our review committees today.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology 

Track-13: Bacteriology

Bacteria are single cellular microorganisms that lack a nuclear membrane and are dividing by binary fission. The study of bacteria called as bacteriology. Bacteriological study helps within the field of agricultural, or soil, bacteriology; clinical diagnostic bacteriology; industrial bacteriology; marine bacteriology; public-health bacteriology; sanitary, or hygienic, bacteriology; and systematic bacteriology. Major researches during this field help in development of the many useful vaccines. the main advantages are the invention of antibiotics that are helpful within the diagnosis of varied sorts of disease. Recombinant bacteria are useful in bacteriologic research to manufacture biomolecules (e.g. interferon) needed for research and patient care.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology 

Track-14: Human Bacteriology

It is the study about the bacterial diseases, their causal agents, morphology, and diagnostics method in human. the foremost common human bacterial diseases are Pneumonia, Cholera, Influenza, Tuberculosis, Measles, Typhoid, Malaria, Anthrax. Mostly recently discovered viruses are valley Virus, Oropouche, Mayaro. The Symptoms of Genus leptospirosis is high fever, headache, chills, and vomiting, and should include jaundice, red eyes, abdominal pain, diarrhea. Some exotic diseases are zoonotic which may pass between animals and humans, like rabies.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology 

Track-15: Plant Bacteriology

Plant bacteriology is a study that involves of bacteria identification, disease etiology, disease cycles, economic impact, epidemiology of plant diseases, disease resistance, the way during which plant diseases affect humans and animals. Some bacteria causes a little proportion of plant diseases, this doesn't mean that these diseases are unimportant. Pathogenic tests are often finished the prevention of disease. Both natural and cultivated plants carry genetics disease resistance, but there are numerous samples of devastating disease.

Related Associations:

Asian society for Pediatric Infectious diseases |  Australian Society for Antimicrobials | Australian society for Infectious Diseases | British Society for Antimicrobial Chemotherapy | Canadian Society for Immunology | Canadian Society of Allergy and Clinical Immunology 

Track 16: Healthcare-associated Infection .

Healthcare-associated Infection (HAIs) is infections that patients get while receiving treatment for medical or surgical conditions, and lots of HAIs are preventable. Modern healthcare employs many sorts of invasive devices and procedures to treat patients and to assist them recover. Infections are often related to procedures (like surgery) and also the devices utilized in medical procedures, like catheters or ventilators. HAIs are important causes of morbidity and mortality within the us and are related to a considerable increase in health care costs annually.

Related Associations:

American Association of Pharmaceutical Scientists | American Society of Hematology | Antibiotic action | Arizona Humane Society | Arizona Humane Society | European Centre for Disease Prevention and Control | Immunization Action Coalition | Infectious Diseases Society of America Honors | International Cytokine SocietyInternational Society for Neuroimmunology 

Market Analysis

The worldwide Antibiotics market is valued at $6,727.29 million in 2014 and is relied upon to develop at a CAGR of 13.03% in the vicinity of 2014 and 2019. Expanding sickness weight of irresistible maladies and expanded subsidizing for social insurance consumption are the vital development drivers for this market amid the conjecture time frame. The pharmaceuticals request piece characterized the major share 0f the Antimicrobials advertise in 2014; while the sustenance claim portion is normal develop at the most bewildering CAGR in the neighbourhood of 2014 and 2019 in the universal Antibiotics cabinet. The worldwide scientific antimicrobials marketplace is predictable to spread USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, rising at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to issues such as the technical progressions; rising occurrence of catching diseases and rising eruption of epidemics; increasing healthcare outflow across the world; and accumulative funding, research grants, and public-private savings in the field of life science researches.

Evolving regions such as Asia-Pacific (including Japan, China, and India) are predictable to develop the new revenue-generating compartments in the marketplace in the next five years. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China, escalating research competences for the progress of ground-breaking and reasonable clinical Antibiotics testing procedures across India, China, and Japan; and increasing occurrences of infectious diseases.

Market Research:

Market research is vital to the development of the industrial market, and endures to be in demand. In 2018, we anticipate delivery of new editions of our report on Antimicrobials Testing in the Global emission.

Global Market Survey:

Antimicrobials scope was esteemed at over USD 24.3 billion in 2017 and will exceed USD 675.2 billion with 7.9% CAGR from 2017 to 2024. At Worldwide Market It is a sole blend of main and subordinate research, with validation and iterations, in order to minimalize nonconformity and current the most precise examination of the manufacturing.

Increasing mandate of new technologies will drive the biotechnology industry size.  we’ve seen wonderful development and alteration in the industrial diagnostics industry, mainly in the food safety sector expertise in all aspects of the market, desirable wide experience in business organization, strategy development and global business, Antibiotics test volumes, marketplace standards and methods used by food creators about the world, based on full interviews with more than 450 food production amenities in America, Europe and Asia, including Japan. Total test capacities have increased 128%, and testing for specific foodborne pathogens like Salmonella and E. coli grew at an even earlier rate.

The worldwide DNA sequencing market is predictable to reach USD 85.5 Million by 2025 from USD 310.1 Million in 2017 growing at a CAGR of 8.5% during the prediction period.

The global market for Food Antibiotics reached nearly $7.1 billion in 2017. This market is expected to grow to nearly $9.6 billion in 2017 and $15.7 billion by 2025, with a compound annual growth rate (CAGR) of 8.1% from 2017 to 2025.

Global Nanotechnology Market was esteemed at $216.2 billion in 2017 and $448.3 billion in 2017. The total market is expected to grow at a compound annual development rate (CAGR) of 19.3% from 2017 through 2025 and reach $828 billion by 2025.

Product:

Based on knowledge, the industry is segmented keen on tissue engineering besides regeneration, fermentation, PCR, nanotechnology, chromatography, DNA sequencing and cell based assay. In 2017, the tissue engineering and regeneration division accounted for maximum income and was cherished at over USD 11.3 billion. However, the nanotechnology, fermentation and cell based assay subdivisions will information moneymaking development owed to increasing R&D enterprises by frequent biotechnological and pharmaceutical companies.

The global clinical Antimicrobials market is respected at $6,727.29 million in 2014 and is predictable to grow at a CAGR of 13.03% between 2014 and 2019. Accumulative disease burden of infectious diseases and increased funding for healthcare expenditure are the vital growth drivers for this market during the forecast period. The pharmaceuticals submission partition accounted for the principal ration of the Antibiotics marketplace in 2014, whereas the food solicitation segment is expected produce at the maximum CAGR amongst 2014 and 2019 in the worldwide Antimicrobials marketplace.

Market Overview:

Numerous microorganisms are used in industrial Antibiotics, comprising laboratory-selected mutants, naturally occurring organisms, and hereditarily modified organisms (GMOs). Antimicrobials research and development is finding cumulative application in oil and gas administrations, the food and beverage industry, and environmental testing organizations.

In addition, the traditional R&D in the biopharmaceutical industry is seeing an upsurge, due to drug development research, which is plateful in the growth of the industrial Antibiotics market.

Increased request for nutraceuticals and other fermented merchandises further drives the importance of industrial application of Antimicrobials on a great scale. Such influences are obliging to determination the industrial marketplace.

However, in the market, there are numerous conflicts experiential regarding the practice of genetically modified organisms in food sources, which are expected to limit the development of the industrial Antibiotics market.

To Collaborate Scientific Professionals around the World

Conference Date October 21-22, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Infectious Diseases and Treatment Journal of Infectious Diseases & Therapy Annals of Infections and Antibiotics Journal of Clinical & Cellular Immunology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by